it's great to see trial progressing as per plan... it'll be interesting to see how slide 13 progresses (Trial is definitely priority 1) i.e. expansion into other cancer tumors.
Also, remember medical trials are a slow process but any biotech given trial approval by FDA comes on the radar of every big pharma company and i am certain their scouts are keeping a very close watch on this one...!
- Forums
- ASX - By Stock
- Ann: Successful Completion of Dosing in First Patient Cohort
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

it's great to see trial progressing as per plan... it'll be...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $50.77K | 12.69M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2602327 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18629873 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2602327 | 0.004 |
42 | 25877937 | 0.003 |
15 | 12900505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18629873 | 23 |
0.006 | 13884684 | 16 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 15.15pm 25/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online